Last reviewed · How we verify

NCT03908658

Inspiratory Muscle Training and Nasal High Flow in Difficult Weaning

Status unknown NA Last updated 12 February 2020
What this trial tests

NA trial testing Inspiratory muscle Training and Nasal High Flow in High-risk for Reintubation Patients in 146 participants. Status unknown.

Timeline
20 March 2019
Primary endpoint
1 January 2021
20 March 2021

Quick facts

Lead sponsorEvangelismos Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment146
Start date20 March 2019
Primary completion1 January 2021
Estimated completion20 March 2021
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

Evangelismos Hospital

Who can join

Adults 18 to 90, any sex, with High-risk for Reintubation Patients or Weaning Outcome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the present study is to investigate the effectiveness of inspiratory muscle training and nasal high flow oxygen in patients with difficult weaning and high-risk for re-intubation. The hypothesis of the study is that starting inspiratory muscle training once patients are awake and co-operative along with the application of nasal high flow oxygen immediately after extubation will have a beneficial effect in preventive re-intubation in these high-risk patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The combination of inspiratory muscle training and high-flow nasal cannula oxygen therapy for promoting weaning outcomes in difficult-to-wean patients: protocol for a randomised controlled trial.
    Patsaki I, Christakou A, Papadopoulos E, Katartzi M, et al · · 2020 · cited 3× · PMID 33015144 · DOI 10.1183/23120541.00088-2020

Verify or expand the search:

Other Evangelismos Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03908658.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing